Sugi Predict

Sugi Predict / Compounds / SCHEMBL18157086

SCHEMBL18157086

SCHEMBL18157086

c1cc(-c2cccc(-n3c4ccccc4c4ccccc43)c2)cc(-c2ccnc(-c3ccc(-c4ccc(-n5c6ccccc6c6ccccc65)cc4)cc3)c2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ GRM5 P41594 4/20 0.38
▸ SMO Q99835 2/20 0.36
▸ PIM1 P11309 1/20 0.36
▸ ASIC3 Q9UHC3 1/20 0.36
▸ TGFBR1 P36897 2/20 0.35
▸ HDAC4 P56524 1/20 0.35
▸ PRKDC P78527 2/20 0.34
▸ MAP4K4 O95819 2/20 0.34
▸ GABRG2 P18507 1/20 0.34
▸ GABRB3 P28472 1/20 0.34
▸ GABRA5 P31644 1/20 0.34
▸ GABRA3 P34903 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ PTK2B Q14289 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ HTR1A P08908 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15034455 0.95 KDM4E (0.46) KDM4EATML3MBTL1GRM5SMO
SCHEMBL18157088 0.92 KDM4E (0.44) KDM4EATML3MBTL1GRM5PIM1
SCHEMBL22920256 0.92 KDM4E (0.44) KDM4EATML3MBTL1GRM5PIM1
SCHEMBL19862586 0.91 KDM4E (0.42) KDM4EATML3MBTL1GRM5SMO
SCHEMBL19628186 0.91 ATM (0.47) KDM4EATML3MBTL1GRM5PIM1
SCHEMBL29741770 0.90 KDM4E (0.46) KDM4EATML3MBTL1GRM5PIM1
SCHEMBL19368121 0.90 KDM4E (0.46) KDM4EATML3MBTL1GRM5PIM1
SCHEMBL17952918 0.90 KDM4E (0.48) KDM4EATML3MBTL1SMOPIM1
SCHEMBL16855925 0.90 KDM4E (0.45) KDM4EATML3MBTL1GRM5SMO
SCHEMBL20223940 0.90 KDM4E (0.40) KDM4EATML3MBTL1GRM5PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10305044-B2 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2019-05-28 — — US disclosed
US-20160308139-A1 Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-10-20 — — US disclosed
US-20160308139-A1 Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-10-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10305044-B2 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device CRY1, CYP1A1, NR2E3 KDM4E 2956/4885ATM 4087/4885L3MBTL1 522/4885
US-20160308139-A1 Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device CRY1, CYP1A1, NR2E3 KDM4E 2956/4885ATM 4087/4885L3MBTL1 522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.